about
NKX2-3 transcriptional regulation of endothelin-1 and VEGF signaling in human intestinal microvascular endothelial cellsA general model for multilocus epistatic interactions in case-control studiesBacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study.Phage tail-like particles kill Clostridium difficile and represent an alternative to conventional antibiotics.Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile.Proton pump inhibitors induce changes in colonocyte gene expression that may affect Clostridium difficile infection.Identification of disease-associated DNA methylation in B cells from Crohn's disease and ulcerative colitis patients.Genes regulated by Nkx2-3 in siRNA-mediated knockdown B cells: implication of endothelin-1 in inflammatory bowel disease.Genes regulated by Nkx2-3 in sporadic and inflammatory bowel disease-associated colorectal cancer cell lines.Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease.NOD2/CARD15 mutations correlate with severe pouchitis after ileal pouch-anal anastomosis.The Microbial Ecosystem Distinguishes Chronically Diseased Tissue from Adjacent Tissue in the Sigmoid Colon of Chronic, Recurrent Diverticulitis PatientsAn interleukin-4 polymorphism is associated with susceptibility to Clostridium difficile infection in patients with inflammatory bowel disease: results of a retrospective cohort study.Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.Single nucleotide polymorphisms of the tcdC gene and presence of the binary toxin gene predict recurrent episodes of Clostridium difficile infection.Mutation in TAGAP is protective of anal sepsis in ileocolic Crohn's disease.Advances in therapeutic bacterial antisense biotechnology.A single nucleotide polymorphism in the STAT5 gene favors colonic as opposed to small-bowel inflammation in Crohn's disease.Antibiotic Treatments for Clostridium difficile Infection Are Associated with Distinct Bacterial and Fungal Community Structures.NOD2 mutations affect muramyl dipeptide stimulation of human B lymphocytes and interact with other IBD-associated genes.The TNFSF15 gene single nucleotide polymorphism rs7848647 is associated with surgical diverticulitis.Genetic risk profiling and gene signature modeling to predict risk of complications after IPAA.DLG5 P1371Q is associated with inflammatory bowel disease and complementary to R30Q in disease susceptibility.Cationic amphiphilic bolaamphiphile-based delivery of antisense oligonucleotides provides a potentially microbiome sparing treatment for C. difficile.Correlation between virulence gene expression and proton pump inhibitors and ambient pH in Clostridium difficile: results of an in vitro study.Mutations in IRGM are associated with more frequent need for surgery in patients with ileocolonic Crohn's diseaseOccurrence of Helicobacter pylori in surface water in the United StatesPresence of Helicobacter pylori in drinking water is associated with clinical infectionAssociation of a Nkx2-3 polymorphism with Crohn's disease and expression of Nkx2-3 is up-regulated in B cell lines and intestinal tissues with Crohn's diseaseFailure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 genePredicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the keyCharacterization of Clostridium difficile isolates from human fecal samples and retail meat from PennsylvaniaT-cell activation Rho GTPase-activating protein expression varies with inflammation location and severity in Crohn's diseaseAssociation of the haem oxygenase-1 gene with inflammatory bowel disease
P50
Q33921294-5D181586-1322-49C5-BA47-4B60BCEC16C6Q34019724-8843E1EB-ADC7-461C-8B44-809EB40DB5C3Q36933685-EE669BF1-58F3-4564-ABE4-EB7C5E931720Q38233839-95AB2834-CD3B-48BB-975C-BAB1A86948EAQ38291228-7AAC948B-0474-4D82-B915-3AC4F4BDCEF6Q38963351-0EEAFCE6-2690-4995-95C1-565631DF5DC0Q39310338-77E318FF-1ABC-4D00-A88C-6065CEB35C39Q39734412-C1402E04-8FF2-4727-A64D-088B61659163Q39737925-9C91F109-3152-4C0B-90AB-D8F4635C0F63Q41122384-E7C4D4D8-75F2-4709-9F4E-7E3D04EFF0E5Q41431841-CB6DF907-8EEC-4651-8F57-3E7AA75B487BQ41436601-224037D5-FD75-4388-AB30-E42504DB5109Q41732682-462F0857-2C8B-4292-A328-08839E82D87DQ43988209-749A5C59-E807-40FF-844E-37DE8D0832A0Q44158817-855F0E2B-EA49-4F2D-99BB-374F784B1DE1Q44172871-5CBAE5F6-A17C-4DA3-A27C-7B149C5C2F91Q47325247-AC257BD0-E2C4-4F7C-8D49-AD76C9777659Q47823462-4ABD6601-1134-4843-9B76-A76FEB0E74D5Q49184018-50B1E52A-90A7-438E-B2A6-DE3D105584EDQ50959099-6D0D0621-CE0D-47E4-BF0C-90D2EA412B31Q51141037-62CF68F8-0112-4B36-BBD2-128321714A78Q51389449-0D9E6910-101A-47F2-9BC9-1ADE67410D77Q51391901-EEFFCDBC-1FBB-4EE4-B8C8-87C9405A2F44Q52576450-DB73EA4E-7CD3-4C5C-BEDC-905F774F93E9Q54253863-221DE409-EB71-4484-913E-E7063894881EQ57118233-F8BE6317-DB02-432E-A645-3B3E850C5EA4Q73265291-15579492-FD43-476F-800F-1DA029A5A136Q77306389-9F74E4B1-1B9E-4502-BB08-237CCCF656F8Q82963595-40286D7D-744C-4B58-A16B-61CAAEF13244Q83712157-FD495DFE-5929-4896-9668-AAB496CDF877Q85243219-37B4F953-90B2-4AFD-B08C-1471BB41E555Q85652761-A4E2C05C-F29A-4290-BE31-37658A10AE08Q87383658-D250445C-997B-47A2-BC80-4E37394A267CQ88668691-6F93C2AB-A0E2-4444-9C1A-4BEEB486163A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John P. Hegarty
@ast
John P. Hegarty
@en
John P. Hegarty
@es
John P. Hegarty
@nl
John P. Hegarty
@sl
type
label
John P. Hegarty
@ast
John P. Hegarty
@en
John P. Hegarty
@es
John P. Hegarty
@nl
John P. Hegarty
@sl
altLabel
J Hegarty
@en
JP Hegarty
@en
prefLabel
John P. Hegarty
@ast
John P. Hegarty
@en
John P. Hegarty
@es
John P. Hegarty
@nl
John P. Hegarty
@sl
P106
P1153
35209957300
P21
P2798
P31
P496
0000-0003-3401-848X